Literature DB >> 11035239

A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology.

D S Burgess1, R W Hastings.   

Abstract

This study evaluated the in vitro pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans. MICs were determined for three clinical isolates according to NCCLS guidelines (M27). Time-kill studies were performed using antifungal concentrations of 0.25-32 x MIC and inocula of 10(3) and 10(5) CFU/ml. At predetermined time points over 72 hours, samples of each inoculum/drug combination were withdrawn and plated using a spiral plater. Colony counts were determined after incubation at 35 degrees C for 48 hours. Area under the kill curves (AUKCs) were plotted versus the AUC/MIC ratios. Inoculum effect was evaluated by calculating an estimated AUKC for the low inoculum then comparing it to the measured low inoculum using the unpaired Student's t-test. The MICs of fluconazole and itraconazole for isolate 97-1199, 97-1061, and 97-585 were 2, 4, 32 microg/ml and 0.03, 0.06, 0. 5 microg/ml, respectively. For amphotericin B, the MIC was 0. 25 microg/ml for each isolate. The triazoles demonstrated fungistatic activity against each isolate at both inocula with the exception of itraconazole against C. neoformans 97-585. Maximal suppression was noted at concentrations 8-16 x MIC correlating with an AUC/MIC of 192 for both inocula. Conversely, amphotericin B was fungicidal and displayed concentration-dependent activity against each isolate at both inocula. Maximal killing was observed at concentrations >4 x MIC for the low inoculum and >8 x MIC for the high inoculum for each isolate. No statistically significant differences were detected between the measured and estimated AUKCs for each antifungal agent. In conclusion, our results suggest that the triazoles were most effective against C. neoformans when concentrations were maintained at 8-16 x MIC. Amphotericin B, on the other hand, was concentration-dependent; thus, greater activity was exerted at higher concentrations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035239     DOI: 10.1016/s0732-8893(00)00173-5

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  12 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 2.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

3.  Toward a clinical antifungal peptoid: Investigations into the therapeutic potential of AEC5.

Authors:  Sabrina K Spicer; Aarthi Subramani; Angelica L Aguila; R Madison Green; Erin E McClelland; Kevin L Bicker
Journal:  Biopolymers       Date:  2019-04-02       Impact factor: 2.505

Review 4.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Comparison of different in vitro tests to detect Cryptococcus neoformans not susceptible to amphotericin B.

Authors:  Susana Córdoba; Walter Vivot; Wanda Szusz; Guillermina Isla; Graciela Davel
Journal:  Mycopathologia       Date:  2015-02-21       Impact factor: 2.574

6.  Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.

Authors:  John E Conte; Jeffrey A Golden; Juliana Kipps; Marina McIver; Elisabeth Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Effects of cytochrome p450 inhibitors on itraconazole and fluconazole induced cytotoxicity in hepatocytes.

Authors:  Nhareet Somchit; Chong Sock Ngee; Azhar Yaakob; Zuraini Ahmad; Zainul Amiruddin Zakaria
Journal:  J Toxicol       Date:  2009-07-16

8.  Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.

Authors:  Susan M Abdel-Rahman; Richard F Jacobs; Joseph Massarella; Ralph E Kauffman; John S Bradley; Hui C Kimko; Gregory L Kearns; Kevin Shalayda; Christopher Curtin; Samuel D Maldonado; Jeffrey L Blumer
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

9.  Effect of heat-treated amphotericin B on renal and fungal cytotoxicity.

Authors:  Karen Bartlett; Edwin Yau; Scott C Hartsel; Alison Hamer; Gina Tsai; Dan Bizzotto; Kishor M Wasan
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

10.  Advances in synthetic approach to and antifungal activity of triazoles.

Authors:  Kumari Shalini; Nitin Kumar; Sushma Drabu; Pramod Kumar Sharma
Journal:  Beilstein J Org Chem       Date:  2011-05-25       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.